Fate Therapeutics, Inc. (FATE) DCF Valuation

Fate Therapeutics, Inc. (FATE) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Fate Therapeutics, Inc. (FATE) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify Fate Therapeutics, Inc. (FATE) valuation with this customizable DCF Calculator! Featuring real Fate Therapeutics, Inc. (FATE) financials and adjustable forecast inputs, you can test scenarios and uncover Fate Therapeutics, Inc. (FATE) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 10.7 31.4 55.8 96.3 63.5 97.9 150.7 232.1 357.5 550.6
Revenue Growth, % 0 194.33 77.66 72.44 -34.03 54.02 54.02 54.02 54.02 54.02
EBITDA -94.2 -125.0 -211.1 -294.6 -172.2 -97.9 -150.7 -232.1 -357.5 -550.6
EBITDA, % -882.06 -397.65 -378.08 -305.95 -271.09 -100 -100 -100 -100 -100
Depreciation 2.2 3.1 5.9 13.8 18.3 16.4 25.3 38.9 60.0 92.4
Depreciation, % 20.53 9.82 10.48 14.29 28.78 16.78 16.78 16.78 16.78 16.78
EBIT -96.4 -128.1 -217.0 -308.4 -190.5 -97.9 -150.7 -232.1 -357.5 -550.6
EBIT, % -902.59 -407.47 -388.56 -320.23 -299.86 -100 -100 -100 -100 -100
Total Cash 221.4 482.9 615.9 436.2 315.2 97.9 150.7 232.1 357.5 550.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 5.5 8.7 38.5 1.8
Account Receivables, % 0 17.54 15.54 39.96 2.87
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0 0.000003181269 0 0.000001038422 0 0.000000844 0.000000844 0.000000844 0.000000844 0.000000844
Accounts Payable 5.8 6.3 8.6 8.3 4.7 20.7 31.9 49.2 75.7 116.7
Accounts Payable, % 54.51 19.99 15.42 8.58 7.43 21.19 21.19 21.19 21.19 21.19
Capital Expenditure -7.4 -4.9 -50.7 -35.6 -6.2 -43.5 -67.0 -103.2 -159.0 -244.9
Capital Expenditure, % -69.24 -15.69 -90.79 -36.93 -9.68 -44.47 -44.47 -44.47 -44.47 -44.47
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -96.0 -125.8 -211.0 -279.2 -190.5 -95.0 -146.4 -225.4 -347.2 -534.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -95.3 -132.7 -256.7 -331.2 -145.3 -119.1 -184.9 -284.8 -438.6 -675.6
WACC, % 9.81 9.78 9.77 9.65 9.81 9.76 9.76 9.76 9.76 9.76
PV UFCF
SUM PV UFCF -1,203.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -689
Terminal Value -8,877
Present Terminal Value -5,572
Enterprise Value -6,775
Net Debt 62
Equity Value -6,837
Diluted Shares Outstanding, MM 98
Equity Value Per Share -69.47

What You Will Get

  • Pre-Filled Financial Model: Fate Therapeutics’ actual data allows for accurate DCF valuation.
  • Full Forecast Control: Modify revenue growth, margins, WACC, and other essential metrics.
  • Instant Calculations: Automatic updates provide immediate results as you adjust inputs.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
  • Customizable and Reusable: Designed for adaptability, enabling repeated use for comprehensive forecasts.

Key Features

  • Customizable Research Variables: Adjust essential metrics such as clinical trial success rates, market penetration, and R&D expenditures.
  • Instant DCF Valuation: Derives intrinsic value, NPV, and other financial outputs in real-time.
  • High-Precision Analysis: Incorporates Fate Therapeutics’ actual financial data for accurate valuation results.
  • Effortless Scenario Simulation: Evaluate various hypotheses and analyze results with ease.
  • Efficiency-Boosting Solution: Avoid the complexity of constructing detailed valuation models from the ground up.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based FATE DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional factors.
  3. Instant Calculations: The model automatically recalculates Fate Therapeutics’ intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
  5. Analyze and Decide: Leverage the results to inform your investment or financial analysis.

Why Choose This Calculator?

  • User-Friendly Interface: Tailored for both newcomers and seasoned professionals.
  • Customizable Inputs: Easily adjust parameters to suit your financial analysis.
  • Real-Time Feedback: Observe immediate changes in Fate Therapeutics’ valuation as you modify inputs.
  • Preloaded Data: Comes equipped with Fate Therapeutics’ actual financial metrics for swift evaluations.
  • Endorsed by Experts: Utilized by investors and analysts for making well-informed decisions.

Who Should Use Fate Therapeutics, Inc. (FATE)?

  • Investors: Make informed choices with a cutting-edge biotechnology investment analysis tool.
  • Biotech Analysts: Streamline your research process with a comprehensive model tailored for biotech evaluations.
  • Healthcare Consultants: Easily modify the framework for client pitches or industry reports.
  • Biotechnology Enthusiasts: Enhance your knowledge of therapeutic innovations through practical case studies.
  • Educators and Students: Utilize it as an effective resource in courses focused on biotechnology and finance.

What the Template Contains

  • Historical Data: Includes Fate Therapeutics’ past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Fate Therapeutics’ intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Fate Therapeutics’ financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

Es wurden keine passenden Produkte gefunden.